Neurological patients face elevated infection risk, study finds

Patients with multiple sclerosis, Alzheimer's, and Parkinson's disease experience higher rates of serious infections, a new study reveals. The finding has implications for healthcare systems managing these growing populations and for pharmaceutical companies developing treatments that balance disease control against infection risk.

Originaltitel: Infections among individuals with multiple sclerosis, Alzheimer's disease and Parkinson's disease